DEFA14A ·Filed Apr 29, 2026

PALI

PALISADE BIO, INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed5mo ago SEC0001493152-26-019631
Proxy solicitation materials
Actionable Insight • Neutral

Monitor future filings for the definitive proxy statement (DEF 14A) to understand the proposals and vote implications. The current filing provides no actionable financial data.

DirectionNeutral
Confidencelow
Horizonweeks
Final — all horizons settled through T+60d
PALI ▲ +1.50% at T+60d
NEUTRAL call ✓ call won +1.50% · α vs SPY -1.61% · entry $2.00 → $2.03
Entry anchored
Apr 29, 2026
via day open
T+1d
-0.50%
call -0.50% · α -0.72%
$1.99
settled 5mo ago
T+5d
-0.50%
call -0.50% · α -2.23%
$1.99
settled 5mo ago
T+20d
+6.00%
call +6.00% · α +0.77%
$2.12
settled 4mo ago
T+60d
+1.50%
call +1.50% · α -1.61%
$2.03
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

PALISADE BIO, INC. filed DEFA14A additional definitive proxy soliciting materials. The substantive content is embedded in images and could not be extracted; therefore, analysis is based on filing metadata only. The filing likely relates to an upcoming shareholder vote, but specific proposals are unknown.

Key Facts

  • Filed DEFA14A (additional definitive proxy soliciting materials)
  • Filed by the registrant (management)
  • Content unavailable due to image-based filing
  • Market cap $326M with 93% bullish analyst consensus

Financial Impact

Not specified

Risk Factors

  • Uncertainty due to incomplete filing content
  • Potential shareholder vote outcome unknown

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001493152-26-019631
Document: 0001493152-26-019631-index-headers.html0001493152-26-019631
Document: 0001493152-26-019631-index.html0001493152-26-019631
Document: 0001493152-26-019631.txt0001493152-26-019631
8 reports for PALI
Performance horizon
Filters
Rows
Reports for PALI — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$2.14 $2.05▼ −4.21%▼ −3.15%$1.45 (−32.48%)
Jul 10, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.89 $2.10▲ +11.11%▲ +7.93%$1.45 (−23.54%)
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$1.97 $2.09▲ +6.09%▲ +3.85%$1.45 (−26.65%)
Jun 11, 2026
16w ago
8-K
NEUTRAL ★ 4/10
$1.71 $1.96▲ +14.62%▲ +12.84%$1.45 (−15.50%)
May 22, 2026
19w ago
EFFECT
NEUTRAL ★ 4/10
$1.95 $1.89▼ −3.08%▼ −1.66%$1.45 (−25.90%)
May 12, 2026
20w ago
S-3
NEUTRAL ★ 5/10
$1.87 $1.78▼ −4.81%▼ −4.20%$1.45 (−22.73%)
Apr 29, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$2.00 $2.12▲ +6.00%▲ +0.77%$1.45 (−27.75%)
Apr 2, 2026
26w ago
8-K
NEUTRAL ★ 5/10
$1.89 $2.00▲ +5.82%▼ −4.06%$1.45 (−23.54%)
Showing 8 of 8

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access